Royalty Report: Medical, Device, Ophthalmological – Collection: 27310

$150.00

Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 9

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 9

Primary Industries

  • Medical
  • Device
  • Ophthalmological
  • Surgical
  • Supply
  • Scientific & Technical Instruments
  • Laser
  • Eye Surgery Procedure
  • Personal Care Products

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 27310

License Grant
The Company entered into agreements for its laser technology for reshaping human eyes.
License Property
The technology allows physicians to re-contour the cornea to adjust for vision impairments, thus eliminating the need for glasses or contact lenses.

IPSCIO Record ID: 118680

License Grant
Licensor granted us a non-exclusive license to its patent covering excimer laser ablation of tissue.  The terms of the license permit us to sublicense our subsidiaries.
License Property
The excimer laser systems and related products are used to perform procedures that correct common refractive vision disorders such as nearsightedness, farsightedness and astigmatism.
Field of Use
Laser vision correction is a surgical procedure for correcting disorders such as nearsightedness, farsightedness and astigmatism using an excimer laser. This procedure uses ultraviolet laser energy to remove tissue from the surface of, and thus sculpt, the cornea into a predetermined shape. Because the excimer laser is a cold laser, it is possible to ablate, or remove precise amounts of corneal tissue without causing thermal damage to surrounding tissue. The goal of laser vision correction is to eliminate or reduce a persons reliance on corrective eyewear.

IPSCIO Record ID: 233446

License Grant
Licensor grants the exclusive, world-wide license under Licensor’s rights in the Licensed Patents to make, have made, use, market and/or sell Products designed and marketed solely for use in the Field of Use; with the right to grant sublicenses to Sublicensees.

Licensor grants the world-wide right to practice the Technology to make, have made, use, market and/or sell Products designed and marketed solely for use in the Field of Use.

License Property
The patents include Multiwavelength Laser Source, Method for Reshaping the Eye, and,  Method for Removing Cataractous Material.

The Product(s) shall mean any goods or services whose manufacture, use or sale in any country would, but for this Agreement, comprise an infringement, including contributory infringement, of one or more Valid Claims; and any goods or services incorporating, or the manufacture, use or sale of which utilizes the Technology.

The technology shall mean all information, manufacturing techniques, data, designs or concepts, whether or not such specific information, manufacturing techniques, data, designs or concepts are or become publicly known or available, developed by Licensor which relate to methods and apparatus for laser-assisted opthalmic surgical procedures.

Field of Use
Field of Use shall refer to use of ultrafast laser medical instruments for human health and human cosmetic applications.

IPSCIO Record ID: 240566

License Grant
Licensor, an individual, hereby grants to Licensee a sole and exclusive, worldwide license under the Patent Rights to make, use, offer for sale and sell the Licensed Products in the Field of Use. Licensee shall have the right to sub-license its rights hereunder to no more than one sub-licensee in each country in the world (reserving no rights to itself in the territory of any such sub-license) on prior written notice (which shall include the name of the sub-licensee and the territorial scope of its sub-license) to Licensor. Each such sub-license shall be subject and subordinate to the terms and conditions of this Agreement, except that no sub-licensee shall have the right to grant further sub-licenses.
License Property
Patent Rights shall mean U.S. Patent Nos. 5,549,632 and 5,984,916
5,549,632 – Method and apparatus for ophthalmic surgery
5,984,916 – Ophthalmic surgical laser and method
Field of Use
Field of Use shall mean use for ophthalmic surgery.

IPSCIO Record ID: 1514

License Grant
The license was granted for use on the exclusive territory to the Swiss Licensee by the Russian Licensor.
License Property
Licenser possesses the 'Technology for Producing Collagen-Based Cross-Linked Drain', and the Licensiate wants to acquired the license on this technology. Technology of production intraocular lenses from collagen co-polimers.   Artificial eye lenses, which are implantated through small sizes, are most perspective.  Several requirements are produced to artificial eye lenses like elasticity, biocompatibility, low specific density and high solidity on rupture.  Artificial eye lenses from collagen co-polimers corresponds to these principles.

Technology of production intraocular lenses from collagen co-polimers Nowadays, intraocular correction is one of the basic medical treatment method of vision body disease.
Artificial eye linses are used not only when cataract, but also for removal of refraction anomalies.
Artificial eye lenses, which are implantated through small sizes, are most perspective. Several requirements are produced to artificial eye lenses like elasticity, biocompatibility, low specific density and high solidity on rupture. Artificial eye lenses from collagen co-polimers corresponds to these principles.
Highest elasticity, hight solidity on rupture are the main quality of these products. It allows to make implantation as tool-making method of injection also.
Lenses, which are maked an special technology, passed experimental and hospital tests successfully and inculcated in wide surgical practice as in Eye Microsurgery Intersectoral Research and Technology Complex so in the other Russian and CIS hospitals.

US patent N 6.286.829 (Russion application N 4745668) 'Biocompatible polymer material and a process for producing same'
USA patent N 5258025 (Russian application N 4881670) 'correctional intraocular lens'

IPSCIO Record ID: 28111

License Grant
The Licensee entered into an Agreement with the Licensor, in October 1998 that grants the Licensee an exclusive License under U.S. Patent No. 5,630,810 relating to a treatment method for preventing the formation of central islands during laser surgery.
License Property
The Licensor owns Patent No. 5,630,810 relating to a treatment method for preventing the formation of central islands during laser surgery. Central islands are a problem generally associated with laser refractive surgery performed with broad beam laser systems used to ablate corneal tissue.
Field of Use
Healthcare Services

IPSCIO Record ID: 5827

License Grant
The Company entered into a Patent License Agreement to obtain the exclusive license to U.S. Patent No.08/781,504 and No. 6,059,772.
License Property
DeepLight®790 is a medical device system for the treatment of glaucoma.

IPSCIO Record ID: 2289

License Grant
We entered into an agreement whereby we acquired the patents, trademarks and technologies related to the X-Chrom contact Lens from Licensors, two individuals.
License Property
X-Chrom introduced the first commercially available contact lenses for colorblindness.

IPSCIO Record ID: 1975

License Grant
The Company licensed it intellectual laser properties; patented ultrafast laser systems for the treatment of a broad range of eye disorders.
License Property
Licensor’s solid-state pico-second (one trillionth of a second) Nd YLF (NeodymiumYitrium-Lithium-Fluoride) laser systems are designed to be more precise than lasers systems utilizing currently available technologies.
Field of Use
The rights granted apply to the healthcare market specializing in ophthalmic medical devices.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.